Phase 4 Clinical Trial to Assess the Safety, Immunogenicity,Three-year Immune Persistence of Inactivated Hepatitis A Vaccine (HAV) and Live Attenuated HAV Vaccine
Latest Information Update: 12 Oct 2023
At a glance
- Drugs Hepatitis A vaccine inactivated (Primary) ; Hepatitis A vaccine live (Primary)
- Indications Hepatitis A
- Focus Pharmacodynamics
- Acronyms HAV
- 28 Jul 2016 Status changed from active, no longer recruiting to completed.
- 15 Oct 2013 New trial record